| Product Name | NFATc2IP |
|---|---|
| Antibody Type | Primary Antibodies |
| Antigen Alias | NFATC2IP antibody; NIP45 antibody; NFATC2-interacting protein antibody; 45 kDa NF-AT-interacting protein antibody; 45 kDa NFAT-interacting protein antibody; Nuclear factor of activated T-cells antibody; cytoplasmic 2-interacting protein antibody; |
| Product description | Plays a role in the inducible expression of cytokine genes in T-cells, especially by increasing NFAT-driven IL-4 production. PTM:Methylation at the N-terminus by PRMT1 modulates interaction with the NFAT complex and results in augmented cytokine production. Contains 1 ubiquitin-like domain. subcellular location:TRAF1 is associated with a fraction of NFATC2IP in the cytoplasm and prevents its translocation to the nucleus. subunit:Interacts with NFATC2, TRAF1, TRAF2 and PRMT1. |
| Immunogen | The antiserum was produced against synthesized peptide derived from human NFATC2IP. AA range:151-200 |
| Clonality | Polyclonal |
|---|---|
| Isotype | IgG |
| Host Species | Rabbit |
| Tested Applications | WB |
| WB:1:500-1:2000 |
|
| Species Reactivity | Human |
| Concentration | 1mg/ml |
| Alternative Names | NFATC2IP antibody NIP45 antibody NFATC2-interacting protein antibody 45 kDa NF-AT-interacting protein antibody 45 kDa NFAT-interacting protein antibody Nuclear factor of activated T-cells antibody cytoplasmic 2-interacting protein antibody |
|---|---|
| Molecular Weight(MW) | 48 kDa |
| SwissProt ID | Q8NCF5 |
|---|
| Positive Control | Brain,Epithelium,Eye,Liver, |
|---|---|
| Application Notes | WB:1:500-1:2000 |
| Form | Liquid |
|---|---|
| Storage Instructions | Store at +4℃ after thawing. Aliquot store at -20℃ or -80℃. Avoid repeated freeze / thaw cycles. |
| Storage Buffer | Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide. |
